Federated Hermes Inc. Sells 39,262 Shares of Intuitive Surgical, Inc. $ISRG

Federated Hermes Inc. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.5% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 273,773 shares of the medical equipment provider’s stock after selling 39,262 shares during the quarter. Federated Hermes Inc.’s holdings in Intuitive Surgical were worth $122,439,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Norges Bank acquired a new stake in Intuitive Surgical in the 2nd quarter valued at about $2,569,260,000. Rakuten Investment Management Inc. acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $388,436,000. Vanguard Group Inc. increased its holdings in shares of Intuitive Surgical by 2.1% in the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares in the last quarter. Jennison Associates LLC increased its holdings in shares of Intuitive Surgical by 20.4% in the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock valued at $1,696,738,000 after purchasing an additional 528,359 shares in the last quarter. Finally, Bessemer Group Inc. raised its position in Intuitive Surgical by 89.3% in the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after purchasing an additional 371,806 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Argus increased their price objective on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. TD Cowen initiated coverage on Intuitive Surgical in a report on Monday. They issued a “buy” rating and a $660.00 price target on the stock. Sanford C. Bernstein lifted their price objective on Intuitive Surgical from $740.00 to $750.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Truist Financial boosted their price objective on Intuitive Surgical from $620.00 to $650.00 and gave the stock a “buy” rating in a report on Thursday, December 18th. Finally, Mizuho set a $575.00 target price on shares of Intuitive Surgical in a research note on Wednesday, October 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $620.41.

Insiders Place Their Bets

In other news, EVP Myriam Curet sold 104 shares of the firm’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. This trade represents a 81.80% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 48,027 shares of company stock worth $27,402,696 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 0.7%

Shares of ISRG opened at $525.04 on Wednesday. The stock has a market cap of $188.21 billion, a P/E ratio of 66.55, a price-to-earnings-growth ratio of 4.12 and a beta of 1.67. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $609.08. The stock’s 50-day moving average price is $561.53 and its two-hundred day moving average price is $511.67.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, beating analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.Intuitive Surgical’s revenue was up 18.8% on a year-over-year basis. During the same period in the prior year, the business posted $2.21 EPS. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: TD Cowen initiated coverage with a Buy and a $660 target, citing the da Vinci 5 rollout and secular procedure growth as catalysts that could drive multi-year revenue and margin upside. TD Cowen initiates coverage
• Positive Sentiment: TD Cowen / TipRanks coverage note expands on the same thesis, highlighting da Vinci 5 rollout execution and secular procedure growth as underpinning a $660 target. TipRanks: TD Cowen Buy Rating
• Positive Sentiment: The FDA granted 510(k) clearance for the da Vinci 5 in select cardiac procedures, expanding the platform into more minimally invasive heart surgeries — a direct product/regulatory win that can support procedure growth and long-term consumable revenue. da Vinci 5 FDA clearance
• Positive Sentiment: HSBC raised its price target to $653 and maintained a Buy, reinforcing bullish analyst sentiment and implying meaningful upside from current levels. HSBC raises PT to $653
• Positive Sentiment: Barclays reiterated its Buy rating, another vote of confidence from the sell-side that supports investor sentiment. Barclays remains Buy
• Positive Sentiment: American Banking News reports a raised price target to $615, adding to the cluster of higher analyst targets that can support upside expectations. Price target raised to $615
• Neutral Sentiment: Interest in ISRG is high among retail/institutional investors (searches up), which can increase short-term volatility but does not by itself change fundamentals. Investors heavily search ISRG
• Negative Sentiment: Zacks highlights rising competitive pressure in China — slower tenders, local favoritism and pricing pressure — which could weigh on growth and margins in a key market if trends accelerate. China competition headwinds
• Negative Sentiment: Robert W. Baird trimmed its price target to $645 — a modest downgrade that could temper upside expectations even though the target remains above current levels. Baird cuts PT to $645

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.